Current and emerging therapies for type 2 diabetes.
Diabetes affects approximately 150 million people worldwide, of which approximately 90% are type 2 diabetics. This article reviews the current and emerging therapies for type 2 diabetes and examines how these therapies affect the etiology and progression of the disease. Although current therapies can only at best delay the progression of type 2 diabetes, it is feasible to prevent pre-diabetics from developing the costly disease. Public awareness of the risk factors for and the symptoms of diabetes are crucial for its prevention and control.
Xu
Jing
J
BioMinerva Group, 11553 Hadar Drive, San Diego, CA 92126, USA. jxu4@san.rr.com
D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000737:chemistry / Q000627:therapeutic use*
D007004:Hypoglycemic Agents